Lanthanum

Chemical formula: La  Molecular mass: 457.835 g/mol  PubChem compound: 168924

Therapeutic indications

Lanthanum is indicated for:

Hyperphosphataemia in chronic renal failure patients

Population group: only adults (18 years old or older)

Lanthanum is indicated in adult patients as a phosphate binding agent for use in the control of hyperphosphataemia in chronic renal failure patients on haemodialysis or continuous ambulatory peritoneal dialysis (CAPD).

Lanthanum is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels ≥1.78 mmol/L in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Lanthanum is contraindicated in the following cases:

Pregnancy

Pregnancy

Hypophosphataemia

Hypophosphatemia

Compounds known to interact with antacids

at least one of
Chloroquine
Hydroxychloroquine
Ketoconazole
Digoxin
Phenytoin
Chlorpromazine

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.